Collaboration aims to leverage Polyrizon's advanced proprietary intranasal delivery platform to support clinical development of Clearmind's drug candidate proprietary MEAI Raanana, Israel, Feb. 06, 20 ...
Novo Nordisk NVO stock fell 7% Thursday as Hims & Hers unveiled a $49 compounded Wegovy alternative, prompting legal action ...
Join Downtown Josh Brown, Michael Batnick, and a rotation of their friends every Friday for expert insight and hot takes on ...
SOXS is best suited for short-term, daily positioning due to compounding risks and potential NAV erosion if held longer.
Hims & Hers Health (NYSE:HIMS) stock fell 10% Friday after the FDA warned it would take action against companies marketing unauthorized versions of approved medications, a day after the telehealth ...
In a Cambodian compound with rooms designed to look like Singapore and Australia police offices, papers were strewn across ...
The supply constraints have driven up prices for Intel's server products in China by more than 10% generally, although ...
Hims said it would sell a copy of the newly launched weight loss pill for $49, far less than the $149 Novo sells the branded pill for.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results